Psyllid ID: psy461


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------
MSNFIRNFSGVENFTADISVCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQKEVQSPLEPESISSENDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSMTDIQDLSSSSNKIAARNDNMGEFVHINNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVSLSRER
ccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEEEEccccccccccHHHHHHHHHHHHHHHHHccHHHHHHHHcEEEcccccHHHHHHHHHHHHHHHHHHHHHHHHcHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEcccccEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHccccccccHHHHHHHHHHcccccccccHHHccccHHHHHHHHHHHHcccccccc
cHHHccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHcccccHHHHHHHHHHHHHHHHHHHcccHHcccccccccccccEEEEccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHcccHHHHHHccHHHHHHHHHHHHHHHHHccc
msnfirnfsgvenftaDISVCVEeekqyypsaffnnieysvpeWEAIITMICLSTLIIGTIIGNIMVVISVFtykplrivQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSAlissppligwndwpevfeadtpcqltqqrgyVVYSslgsffiplAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHnvqkevqsplepesissendtksgkhknkkrkkTKKKNVQKnnnnnnnsflrpvlinedsmtdiqdlssssnkiaarndnmgefvhinnnettftnktisddislasiksdkkpnngngchvktpvphelnlkstsvkSEVSIVVIQAPSTQVVKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLmyvslpfcdtccmsdrLINFITWLGyinsginpiiYTIFNLDFRKSFKRLLNKVSLSRER
msnfirnfsgvenftADISVCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRakasklnivkqttlhnvqkevqsplepesissendtksgkhknkkrkktkkknvqknnnnnnnsflrpVLINEDSMTDIQDLSSSSNKIAARNDNMGEFVHINnnettftnktisDDISLASIksdkkpnngnGCHVKTPVPHELNLKSTSVKSEVSIVVIqapstqvvKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLlnkvslsrer
MSNFIRNFSGVENFTADISVCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWllsalissppliGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQKEVQSPLEPESISSENDTksgkhknkkrkktkkknvqknnnnnnnSFLRPVLINEDSMTDIQDLSSSSNKIAARNDNMGEFVHINNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVSLSRER
***FIRNFSGVENFTADISVCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDR****KLNIV*****************************************************************************************FVHIN***************************************************EVSIVVIQAPSTQVVKQFIEEKQKISL**ERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLN********
*******FSGVENFTADISVCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLAT*********************************************************************************************NKIAARNDNMGEFVHINNNETTFTNKTISDDI***************************************************************SKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVSLS***
MSNFIRNFSGVENFTADISVCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNV************************************VQKNNNNNNNSFLRPVLINEDSMTDIQDLSSSSNKIAARNDNMGEFVHINNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLN********
***********************************NIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRD*****************************************************************************************************************************************************************************IEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVSLSR**
oooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MSNFIRNFSGVENFTADISVCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQKEVQSPLEPESISSENDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSMTDIQDLSSSSNKIAARNDNMGEFVHINNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVSLSRER
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query507 2.2.26 [Sep-21-2011]
Q17232479 Octopamine receptor OS=Bo N/A N/A 0.840 0.889 0.515 1e-141
Q25188477 Octopamine receptor OS=He N/A N/A 0.848 0.901 0.516 1e-140
Q25321484 Tyramine receptor 1 OS=Lo N/A N/A 0.854 0.894 0.561 1e-136
Q25322484 Putative tyramine recepto N/A N/A 0.854 0.894 0.559 1e-136
P22270601 Tyramine/octopamine recep yes N/A 0.907 0.765 0.502 1e-131
O02213455 Tyramine receptor ser-2 O yes N/A 0.773 0.861 0.369 3e-82
Q93127379 Probable G-protein couple N/A N/A 0.447 0.598 0.594 9e-74
Q0EAB6422 5-hydroxytryptamine recep yes N/A 0.745 0.895 0.339 1e-66
Q9N298422 5-hydroxytryptamine recep yes N/A 0.741 0.890 0.336 3e-66
P08908422 5-hydroxytryptamine recep yes N/A 0.741 0.890 0.336 5e-66
>sp|Q17232|OAR_BOMMO Octopamine receptor OS=Bombyx mori PE=2 SV=1 Back     alignment and function desciption
 Score =  502 bits (1292), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 257/499 (51%), Positives = 336/499 (67%), Gaps = 73/499 (14%)

Query: 20  VCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRI 79
           VC   ++   P +F   I  +VPEWEAI T I L+ +II T++GNI+V++SVFTYKPLRI
Sbjct: 30  VCAVADEPNIPCSF--GISLAVPEWEAICTAIILTMIIISTVVGNILVILSVFTYKPLRI 87

Query: 80  VQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCA 139
           VQNFFIVSLAVADLTVAI VLPL++ Y + G+W+FGI +CK+WLT D++CCT+SILNLCA
Sbjct: 88  VQNFFIVSLAVADLTVAILVLPLNVAYSILGQWVFGIYVCKMWLTCDIMCCTSSILNLCA 147

Query: 140 IALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQ 199
           IALDRYWAITDP+ YAQ+RT++RV+ MI  VW+LS +ISSPPL+GWNDWPEVFE DTPC+
Sbjct: 148 IALDRYWAITDPINYAQKRTLERVLFMIGIVWILSLVISSPPLLGWNDWPEVFEPDTPCR 207

Query: 200 LTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQK 259
           LT Q G+V++SS GSF+IPL IMT+VY EI+LATKKRLRDRAKA+K++ +         K
Sbjct: 208 LTSQPGFVIFSSSGSFYIPLVIMTVVYFEIYLATKKRLRDRAKATKISTISSGRNKYETK 267

Query: 260 EVQSPLEPESISSE---NDTKSG---------KHKNKK--RKKTKKKNVQKNNNNNNNSF 305
           E   P + +S+SS+   N+ + G         KH+ +K   KK  K+     ++ ++N  
Sbjct: 268 E-SDPNDQDSVSSDANPNEHQGGTRLVAENEKKHRTRKLTPKKKPKRRYWSKDDKSHNKL 326

Query: 306 LRPVLINEDSMTDI------QDLSSSSNKIAARNDNMGEFVHINNNETTFTNKTISDDIS 359
           + P+L NE+S+TDI      ++ SS SN      DNM E                     
Sbjct: 327 IIPILSNENSVTDIGENLENRNTSSESNSKETHEDNMIEITE------------------ 368

Query: 360 LASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKI 419
            A +K  K+P                                    T  V QFIEEKQ+I
Sbjct: 369 AAPVKIQKRPKQNQ--------------------------------TNAVYQFIEEKQRI 396

Query: 420 SLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGIN 479
           SL++ERRAARTLGIIMGVFV CWLPFF++Y+ +PFC +CC+S++ INFITWLGY+NS +N
Sbjct: 397 SLTRERRAARTLGIIMGVFVVCWLPFFVIYLVIPFCVSCCLSNKFINFITWLGYVNSALN 456

Query: 480 PIIYTIFNLDFRKSFKRLL 498
           P+IYTIFN+DFR++FK+LL
Sbjct: 457 PLIYTIFNMDFRRAFKKLL 475




Receptor for octopamine. Octopamine (OA) is a neurotransmitter, neurohormone, and neuromodulator in invertebrates. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
Bombyx mori (taxid: 7091)
>sp|Q25188|OAR_HELVI Octopamine receptor OS=Heliothis virescens PE=2 SV=1 Back     alignment and function description
>sp|Q25321|OAR1_LOCMI Tyramine receptor 1 OS=Locusta migratoria GN=GCR1 PE=1 SV=1 Back     alignment and function description
>sp|Q25322|OAR2_LOCMI Putative tyramine receptor 2 OS=Locusta migratoria GN=GCR2 PE=2 SV=1 Back     alignment and function description
>sp|P22270|OAR_DROME Tyramine/octopamine receptor OS=Drosophila melanogaster GN=Oct-TyrR PE=2 SV=2 Back     alignment and function description
>sp|O02213|SER2_CAEEL Tyramine receptor ser-2 OS=Caenorhabditis elegans GN=ser-2 PE=1 SV=4 Back     alignment and function description
>sp|Q93127|GPR18_BALAM Probable G-protein coupled receptor No18 OS=Balanus amphitrite PE=3 SV=1 Back     alignment and function description
>sp|Q0EAB6|5HT1A_HORSE 5-hydroxytryptamine receptor 1A OS=Equus caballus GN=HTR1A PE=2 SV=1 Back     alignment and function description
>sp|Q9N298|5HT1A_PANTR 5-hydroxytryptamine receptor 1A OS=Pan troglodytes GN=HTR1A PE=3 SV=1 Back     alignment and function description
>sp|P08908|5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query507
42662203479 tyramine receptor [Bombyx mori] 0.840 0.889 0.517 1e-140
13173421477 putative octopamine receptor [Mamestra b 0.846 0.899 0.509 1e-139
112984406479 octopamine receptor [Bombyx mori] gi|249 0.840 0.889 0.515 1e-139
223673360477 tyramine/octopamine receptor [Agrotis ip 0.846 0.899 0.507 1e-139
2495005477 RecName: Full=Octopamine receptor gi|119 0.848 0.901 0.516 1e-138
210076544478 Oct/Tyr receptor [Spodoptera littoralis] 0.846 0.897 0.508 1e-138
198463614 625 GA20386 [Drosophila pseudoobscura pseudo 0.883 0.716 0.516 1e-137
195172881 621 GL25423 [Drosophila persimilis] gi|19411 0.883 0.721 0.516 1e-137
195128241 611 GI13571 [Drosophila mojavensis] gi|19392 0.932 0.774 0.507 1e-136
3024246484 RecName: Full=Tyramine receptor 1; AltNa 0.854 0.894 0.561 1e-134
>gi|42662203|dbj|BAD11157.1| tyramine receptor [Bombyx mori] Back     alignment and taxonomy information
 Score =  505 bits (1301), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 258/499 (51%), Positives = 336/499 (67%), Gaps = 73/499 (14%)

Query: 20  VCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRI 79
           VC   ++  YPS+F   I  +VPEWEAI T I L+ +II T++GNI+V++SVFTYKPLRI
Sbjct: 30  VCAVADEPKYPSSF--GISLAVPEWEAICTAIILTMIIISTVVGNILVILSVFTYKPLRI 87

Query: 80  VQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCA 139
           VQNFFIVSLAVADLTVAI VLPL++ Y + G+W+FGI +CK+WLT D++CCT+SILNLCA
Sbjct: 88  VQNFFIVSLAVADLTVAILVLPLNVAYSILGQWVFGIYVCKMWLTCDIMCCTSSILNLCA 147

Query: 140 IALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQ 199
           IALDRYWAITDP+ YAQ+RT++RV+ MI  VW+LS +ISSPPL+GWNDWPEVFE DTPC+
Sbjct: 148 IALDRYWAITDPINYAQKRTLERVLFMIGIVWILSLVISSPPLLGWNDWPEVFEPDTPCR 207

Query: 200 LTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVK--------Q 251
           LT Q G+V++SS GSF+IPL IMT+VY EI+LATKKRLRDRAKA+K++ +         +
Sbjct: 208 LTSQPGFVIFSSSGSFYIPLVIMTVVYFEIYLATKKRLRDRAKATKISTISSGRNKYETK 267

Query: 252 TTLHNVQKEVQSPLEPES------ISSENDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSF 305
            +  N Q  V S   P        + +EN+ K    K   +KK K++   K++ ++N   
Sbjct: 268 ESDPNDQDSVSSDANPNEHQGSTRLVAENEKKHRTRKLTPKKKPKRRYWSKDDKSHNK-L 326

Query: 306 LRPVLINEDSMTDI------QDLSSSSNKIAARNDNMGEFVHINNNETTFTNKTISDDIS 359
           + P+L NE+S+TDI      ++ SS SN      DNM E                     
Sbjct: 327 IIPILSNENSVTDIGENLENRNTSSESNSKETHEDNMIEITE------------------ 368

Query: 360 LASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKI 419
            A +K  K+P                                    T  V QFIEEKQ+I
Sbjct: 369 AAPVKIQKRPKQNQ--------------------------------TNAVYQFIEEKQRI 396

Query: 420 SLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGIN 479
           SL++ERRAARTLGIIMGVFV CWLPFF++Y+ +PFC +CC+S++ INFITWLGY+NS +N
Sbjct: 397 SLTRERRAARTLGIIMGVFVVCWLPFFVIYLVIPFCVSCCLSNKFINFITWLGYVNSALN 456

Query: 480 PIIYTIFNLDFRKSFKRLL 498
           P+IYTIFN+DFR++FK+LL
Sbjct: 457 PLIYTIFNMDFRRAFKKLL 475




Source: Bombyx mori

Species: Bombyx mori

Genus: Bombyx

Family: Bombycidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|13173421|gb|AAK14402.1|AF343878_1 putative octopamine receptor [Mamestra brassicae] Back     alignment and taxonomy information
>gi|112984406|ref|NP_001037504.1| octopamine receptor [Bombyx mori] gi|2495004|sp|Q17232.1|OAR_BOMMO RecName: Full=Octopamine receptor gi|1197192|emb|CAA64865.1| octopamine receptor [Bombyx mori] Back     alignment and taxonomy information
>gi|223673360|gb|ACN12797.1| tyramine/octopamine receptor [Agrotis ipsilon] Back     alignment and taxonomy information
>gi|2495005|sp|Q25188.1|OAR_HELVI RecName: Full=Octopamine receptor gi|1197330|emb|CAA64864.1| octopamine receptor [Heliothis virescens] Back     alignment and taxonomy information
>gi|210076544|gb|ACJ06651.1| Oct/Tyr receptor [Spodoptera littoralis] Back     alignment and taxonomy information
>gi|198463614|ref|XP_001352884.2| GA20386 [Drosophila pseudoobscura pseudoobscura] gi|198151336|gb|EAL30385.2| GA20386 [Drosophila pseudoobscura pseudoobscura] Back     alignment and taxonomy information
>gi|195172881|ref|XP_002027224.1| GL25423 [Drosophila persimilis] gi|194113045|gb|EDW35088.1| GL25423 [Drosophila persimilis] Back     alignment and taxonomy information
>gi|195128241|ref|XP_002008573.1| GI13571 [Drosophila mojavensis] gi|193920182|gb|EDW19049.1| GI13571 [Drosophila mojavensis] Back     alignment and taxonomy information
>gi|3024246|sp|Q25321.1|OAR1_LOCMI RecName: Full=Tyramine receptor 1; AltName: Full=Tyr-Loc1 gi|871405|emb|CAA49268.1| monophenolic amine tyramine [Locusta migratoria migratorioides] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query507
FB|FBgn0004514601 Oct-TyrR "Octopamine-Tyramine 0.465 0.392 0.616 4.5e-122
WB|WBGene00004777455 ser-2 [Caenorhabditis elegans 0.408 0.454 0.452 3.6e-78
UNIPROTKB|O02213455 ser-2 "Tyramine receptor ser-2 0.408 0.454 0.452 3.6e-78
UNIPROTKB|E1BZQ1377 HTR1D "Uncharacterized protein 0.414 0.557 0.398 8.7e-67
UNIPROTKB|F1NAZ2422 HTR1A "Uncharacterized protein 0.408 0.490 0.394 3.7e-66
UNIPROTKB|F6Q2H9422 HTR1A "Uncharacterized protein 0.441 0.530 0.373 4.8e-66
ZFIN|ZDB-GENE-071203-1398 htr1aa "5-hydroxytryptamine (s 0.390 0.497 0.407 7.7e-66
UNIPROTKB|Q98998408 htr1a "5-hydroxytryptamine rec 0.429 0.534 0.382 9.8e-66
UNIPROTKB|F1SKV3422 HTR1A "Uncharacterized protein 0.435 0.523 0.378 2.6e-65
UNIPROTKB|P08908422 HTR1A "5-hydroxytryptamine rec 0.437 0.526 0.377 2.6e-65
FB|FBgn0004514 Oct-TyrR "Octopamine-Tyramine receptor" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 794 (284.6 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
 Identities = 148/240 (61%), Positives = 190/240 (79%)

Query:    37 IEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVA 96
             ++ +VPEWEA++T + LS +I+ TIIGNI+V++SVFTYKPLRIVQNFFIVSLAVADLTVA
Sbjct:   100 LQLAVPEWEALLTALVLSVIIVLTIIGNILVILSVFTYKPLRIVQNFFIVSLAVADLTVA 159

Query:    97 IFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQ 156
             + VLP ++ Y + GRW FGI +CK+WLT DVLCCT+SILNLCAIALDRYWAITDP+ YAQ
Sbjct:   160 LLVLPFNVAYSILGRWEFGIHLCKLWLTCDVLCCTSSILNLCAIALDRYWAITDPINYAQ 219

Query:   157 QRTIKRVMMMIMYVWXXXXXXXXXXXXGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFF 216
             +RT+ RV+++I  VW            GWNDWP+ F + TPC+LT QRGYV+YSSLGSFF
Sbjct:   220 KRTVGRVLLLISGVWLLSLLISSPPLIGWNDWPDEFTSATPCELTSQRGYVIYSSLGSFF 279

Query:   217 IPLAIMTLVYVEIFLATKKRLRDRAKASKLNIV--KQTTLHNVQKEVQSPLEPESISSEN 274
             IPLAIMT+VY+EIF+AT++RLR+RA+A+KLN +  K T L  +     SP+   +  S++
Sbjct:   280 IPLAIMTIVYIEIFVATRRRLRERARANKLNTIALKSTELEPMANS--SPVAASNSGSKS 337


GO:0005886 "plasma membrane" evidence=ISS
GO:0008227 "G-protein coupled amine receptor activity" evidence=ISS
GO:0005887 "integral to plasma membrane" evidence=NAS
GO:0004989 "octopamine receptor activity" evidence=IEA;NAS
GO:0008226 "tyramine receptor activity" evidence=NAS
GO:0007608 "sensory perception of smell" evidence=IMP
GO:0007211 "octopamine or tyramine signaling pathway" evidence=ISS;IMP
GO:0016021 "integral to membrane" evidence=IEA;ISS
WB|WBGene00004777 ser-2 [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
UNIPROTKB|O02213 ser-2 "Tyramine receptor ser-2" [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
UNIPROTKB|E1BZQ1 HTR1D "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1NAZ2 HTR1A "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F6Q2H9 HTR1A "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-071203-1 htr1aa "5-hydroxytryptamine (serotonin) receptor 1A a" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
UNIPROTKB|Q98998 htr1a "5-hydroxytryptamine receptor 1A" [Xenopus laevis (taxid:8355)] Back     alignment and assigned GO terms
UNIPROTKB|F1SKV3 HTR1A "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|P08908 HTR1A "5-hydroxytryptamine receptor 1A" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

ID ?Name ?Annotated EC number ?Identity ?Query coverage ?Hit coverage ?RBH(Q2H) ?RBH(H2Q) ?
P22270OAR_DROMENo assigned EC number0.50290.90720.7653yesN/A
Q9N2985HT1A_PANTRNo assigned EC number0.33620.74160.8909yesN/A
Q01337ADA2C_MOUSENo assigned EC number0.31980.76330.8449yesN/A
P089085HT1A_HUMANNo assigned EC number0.33620.74160.8909yesN/A
Q17232OAR_BOMMONo assigned EC number0.51500.84020.8893N/AN/A
O02213SER2_CAEELNo assigned EC number0.36940.77310.8615yesN/A
Q25322OAR2_LOCMINo assigned EC number0.55930.85400.8946N/AN/A
P22909ADA2A_RATNo assigned EC number0.31810.83230.9377yesN/A
Q25321OAR1_LOCMINo assigned EC number0.56140.85400.8946N/AN/A
Q0EAB65HT1A_HORSENo assigned EC number0.33990.74550.8957yesN/A
Q25188OAR_HELVINo assigned EC number0.51690.84810.9014N/AN/A

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query507
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 2e-44
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 1e-16
PHA03087335 PHA03087, PHA03087, G protein-coupled chemokine re 7e-13
PHA02638417 PHA02638, PHA02638, CC chemokine receptor-like pro 4e-11
PHA02834323 PHA02834, PHA02834, chemokine receptor-like protei 8e-06
PHA03235409 PHA03235, PHA03235, DNA packaging protein UL33; Pr 0.004
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
 Score =  156 bits (396), Expect = 2e-44
 Identities = 62/173 (35%), Positives = 93/173 (53%), Gaps = 5/173 (2%)

Query: 71  VFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCC 130
           +   K LR   N F+++LAVADL   + + P +L Y + G W FG  +CK+     V+  
Sbjct: 3   ILRTKKLRTPTNIFLLNLAVADLLFLLTLPPWALYYLVGGDWPFGDALCKLVGFLFVVNG 62

Query: 131 TASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPE 190
            ASIL L AI++DRY AI  PL Y + RT +R  ++I+ VW+L+ L+S PPL+       
Sbjct: 63  YASILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWLRTV 122

Query: 191 VFEADTPCQLT-----QQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLR 238
                T C +       +R Y + S+L  F +PL ++ + Y  I    +KR R
Sbjct: 123 EEGNVTTCLIDFPEESTKRSYTLLSTLLGFVLPLLVILVCYTLILRTLRKRAR 175


This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251

>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
>gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|223017 PHA03235, PHA03235, DNA packaging protein UL33; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 507
KOG4220|consensus503 100.0
KOG4219|consensus423 100.0
PHA03234338 DNA packaging protein UL33; Provisional 100.0
PHA03235409 DNA packaging protein UL33; Provisional 100.0
PHA02834323 chemokine receptor-like protein; Provisional 100.0
PHA02638417 CC chemokine receptor-like protein; Provisional 100.0
PHA03087335 G protein-coupled chemokine receptor-like protein; 100.0
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 100.0
KOG2087|consensus363 99.93
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 99.9
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 99.87
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 99.83
PF05296303 TAS2R: Mammalian taste receptor protein (TAS2R); I 99.75
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 99.71
PF05462303 Dicty_CAR: Slime mold cyclic AMP receptor 99.68
PF10321313 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept 99.65
PF10317292 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept 99.26
PF11710201 Git3: G protein-coupled glucose receptor regulatin 99.25
PF03402265 V1R: Vomeronasal organ pheromone receptor family, 99.03
PF10292324 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c 99.02
KOG4193|consensus610 98.99
PF02118275 Srg: Srg family chemoreceptor; InterPro: IPR000609 98.88
PF10327303 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept 98.84
KOG4564|consensus473 98.79
PF02101405 Ocular_alb: Ocular albinism type 1 protein; InterP 98.79
PF10326307 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept 98.67
PF10318302 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept 98.57
PF10316273 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep 98.52
PF02117328 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept 98.38
PF10319310 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept 98.37
PF04789305 DUF621: Protein of unknown function (DUF621); Inte 98.34
PF03125365 Sre: C. elegans Sre G protein-coupled chemorecepto 98.33
PF00002242 7tm_2: 7 transmembrane receptor (Secretin family); 98.04
PF02076283 STE3: Pheromone A receptor; InterPro: IPR001499 G- 97.35
PF01534328 Frizzled: Frizzled/Smoothened family membrane regi 97.31
PF10322307 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept 97.21
PF1197076 Git3_C: G protein-coupled glucose receptor regulat 97.21
PF06681226 DUF1182: Protein of unknown function (DUF1182); In 96.32
PF02175236 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept 95.89
PF03383153 Serpentine_r_xa: Caenorhabditis serpentine recepto 94.11
KOG4289|consensus 2531 92.72
>KOG4220|consensus Back     alignment and domain information
Probab=100.00  E-value=2.5e-52  Score=381.33  Aligned_cols=456  Identities=27%  Similarity=0.418  Sum_probs=277.5

Q ss_pred             CcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCcchhHHHHHHHHHHHHHHHHHHHHHHHHHHhhCcccccchhH
Q psy461           40 SVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIIC  119 (507)
Q Consensus        40 ~~~~~~~~~~~~~~~ii~~~gi~gN~lvi~~i~~~~~lr~~~~~ll~~LaisDll~~~~~~p~~i~~~~~~~~~~~~~~C  119 (507)
                      ....++-++.+++..+++++.++||++|++.+.-.++|++..|+||++||++||++|++.+|++..+.+.+.|.+|...|
T Consensus        24 ~~~~~q~v~i~~v~~~lsLVTv~GNlLVmiSfKvnrqLqTVnNYfLfSLAcADliIG~~SMnl~t~Y~lmg~W~LG~~~C  103 (503)
T KOG4220|consen   24 RYETWQVVFIVVVTGSLSLVTVVGNLLVMISFKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTTYTLMGYWPLGPLVC  103 (503)
T ss_pred             CccceEEEeeehhhhHHHHHhhhccEEEEEEEEecceeeeecceeehHHHHhhhhhheeechHHHHHHHHcccccchHHH
Confidence            34456667788899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhHHHHHHHHHHHHHHHHHHHHHhhcccccccccccchhhhhHHHHHHHHHHHHhhccccccCCCc-cccCCCcc
Q psy461          120 KIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPE-VFEADTPC  198 (507)
Q Consensus       120 ~~~~~~~~~~~~~S~~~l~~IaidRy~aI~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~-~~~~~~~c  198 (507)
                      .++..+.++...+|++.++.|++|||+.|.+|+.|+.+.|++++..+|++.|++++++..|.++.|....+ .....+.|
T Consensus       104 dlWLalDYvaSNASVmNLLiISFDRYFsVTrPLtYrakRTtkrA~~MI~~AW~iSfiLWaPaIl~WqyivGkrTv~~~eC  183 (503)
T KOG4220|consen  104 DLWLALDYVASNASVMNLLIISFDRYFSVTRPLTYRAKRTTKRAGLMIGAAWVLSFVLWAPAILFWQYIVGKRTVPDGEC  183 (503)
T ss_pred             HHHHHHHHHhhhhhhhhhheeeeecceeecccccccccccchHHHHHHHHHHHHHHHHHHHHHHhhHhheeeeecCCCce
Confidence            99999999999999999999999999999999999999999999999999999999999998887765433 34556678


Q ss_pred             ccCCc--chhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhcchhcccccccccccccCCCCCCCccccCCC
Q psy461          199 QLTQQ--RGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQKEVQSPLEPESISSENDT  276 (507)
Q Consensus       199 ~~~~~--~~~~~~~~~~~~~ip~~vi~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (507)
                      ..++.  ........+..|.+|..+|+++|++|++..+++.+..........+.........++..........++..+.
T Consensus       184 ~iQFlsnp~iTfGTAiAAFYlPVtiM~~LY~rIyret~kR~k~~~~lq~s~~~~~~~~~~~~~~~~~~~~s~r~~p~~~~  263 (503)
T KOG4220|consen  184 YIQFLSNPAITFGTAIAAFYLPVTIMTILYWRIYRETRKRQKELAKLQASLPSFSAIKLSPESPKGDSKSSGRSSPSEEG  263 (503)
T ss_pred             EEEeecCceeehhHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhhhcccccccccccccCcccccccccCCCCCCCcccc
Confidence            77653  3345566778899999999999999999999988876655322211111111111100000000000010100


Q ss_pred             CCCccccccccccchhhcccCCCCCCCccccccccccCCc-cccccccccchhc--cccCC---CCccceeecCCCcccc
Q psy461          277 KSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSM-TDIQDLSSSSNKI--AARND---NMGEFVHINNNETTFT  350 (507)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~  350 (507)
                      .+.+..+.... ..+....+      .....+.....+.+ ....+.....-++  .+..+   ....+.+.+...++..
T Consensus       264 ~~~~~~~~~~~-~~k~ps~~------~~~~~~~s~~edsd~~~~~s~~~s~~~~~~se~~~~~~v~~~~~~~~~~~D~~~  336 (503)
T KOG4220|consen  264 KREPLTNGCIS-NSKAPSLT------PTESWKPSEKEDSDESSSESLTSSPLERPGSELSEIEAVVAKMPANQRKVDEEG  336 (503)
T ss_pred             ccccCCCCccc-cccCcccC------CccCCCCccccccccccccccccCCccccccccccccceeccCCCCcCCCCccc
Confidence            11111111000 00000000      00000000000000 0000000000000  00000   0000000000001000


Q ss_pred             c-cccccccccccccCCCCCCCCCCCCcCCCCCCCCCccccccccccchhhccCCCh----hhHHHHHHHHHhhhhHHHH
Q psy461          351 N-KTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPST----QVVKQFIEEKQKISLSKER  425 (507)
Q Consensus       351 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  425 (507)
                      . ...+.......+.+++..+....-......+.+...+..+..+ .++  ..+.+.    ...+.+.+++++-...+|+
T Consensus       337 ~~~~i~i~~~~~~p~s~sc~p~~~~t~~~~~s~~ns~~gk~r~~~-~~~--~~~~~~kkf~~~~r~q~~k~k~~~~~rEr  413 (503)
T KOG4220|consen  337 LNTLIQIPTDQMLPKSDSCVPIFSATDTDKTTDTNSGAGKRRAGP-VAR--KTGLDYKKFAKRARSQSRKKKKMSLVRER  413 (503)
T ss_pred             cccccccccccCCCCCCcccccccccccccCCccCccccccccCc-ccc--ccchhhhhhhhhhhhhhhhhcchhhHHHH
Confidence            0 0011111111011111111000000000000000000000100 000  000000    1111122222233348999


Q ss_pred             HHHHHHHHHHHHHHhhchhHHHHHhhccccCCccCchhHHHHHHHHHhhhcchhhHHHHhhcHHHHHHHHHHHHhhhhcc
Q psy461          426 RAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVSLSR  505 (507)
Q Consensus       426 r~~k~l~~i~~~f~i~w~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~NPiIY~~~n~~fR~~~~~l~~~~~~~~  505 (507)
                      |++|++.+|.+.|++||.||.|+.++..++.++ ....+..+..||.|+||.+||+.|.+.|..||+.+++++.|...++
T Consensus       414 KAAkTLsAILlAFIiTWtPYNImVlv~tFC~~C-iP~tlW~~gYwLCYINSTiNP~CYALCNatFrkTfk~lL~Cr~~~~  492 (503)
T KOG4220|consen  414 KAAKTLSAILLAFILTWTPYNIMVLVNTFCKNC-IPETLWTFGYWLCYINSTINPLCYALCNATFRKTFKRLLLCRWKKR  492 (503)
T ss_pred             HHHHHHHHHHHHHHHHcccceeeeehHhhcccc-cchhHhhhhhheeeecccccHHHHHHHhHHHHHHHHHhheeeeccc
Confidence            999999999999999999999999999998865 5677888999999999999999999999999999999997766554


Q ss_pred             c
Q psy461          506 E  506 (507)
Q Consensus       506 ~  506 (507)
                      +
T Consensus       493 ~  493 (503)
T KOG4220|consen  493 R  493 (503)
T ss_pred             c
Confidence            3



>KOG4219|consensus Back     alignment and domain information
>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] Back     alignment and domain information
>PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4193|consensus Back     alignment and domain information
>PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4564|consensus Back     alignment and domain information
>PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes Back     alignment and domain information
>PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity Back     alignment and domain information
>PF03125 Sre: C Back     alignment and domain information
>PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] Back     alignment and domain information
>PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans Back     alignment and domain information
>PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4289|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query507
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 4e-29
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 1e-12
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 2e-28
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 2e-15
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 2e-28
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 5e-15
3p0g_A501 Structure Of A Nanobody-Stabilized Active State Of 3e-28
3p0g_A501 Structure Of A Nanobody-Stabilized Active State Of 1e-12
3kj6_A366 Crystal Structure Of A Methylated Beta2 Adrenergic 3e-28
3kj6_A366 Crystal Structure Of A Methylated Beta2 Adrenergic 2e-12
2rh1_A500 High Resolution Crystal Structure Of Human B2-Adren 3e-28
2rh1_A500 High Resolution Crystal Structure Of Human B2-Adren 1e-12
2r4r_A365 Crystal Structure Of The Human Beta2 Adrenoceptor L 4e-28
2r4r_A365 Crystal Structure Of The Human Beta2 Adrenoceptor L 2e-12
3d4s_A490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 4e-28
3d4s_A490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 2e-12
2r4s_A342 Crystal Structure Of The Human Beta2 Adrenoceptor L 7e-28
2r4s_A342 Crystal Structure Of The Human Beta2 Adrenoceptor L 3e-12
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 8e-28
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 6e-13
3pds_A458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 3e-27
3pds_A458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 2e-12
3pbl_A481 Structure Of The Human Dopamine D3 Receptor In Comp 6e-27
3pbl_A481 Structure Of The Human Dopamine D3 Receptor In Comp 1e-19
3uon_A467 Structure Of The Human M2 Muscarinic Acetylcholine 7e-25
3uon_A467 Structure Of The Human M2 Muscarinic Acetylcholine 3e-08
4daj_A479 Structure Of The M3 Muscarinic Acetylcholine Recept 2e-24
4daj_A479 Structure Of The M3 Muscarinic Acetylcholine Recept 3e-11
3rze_A452 Structure Of The Human Histamine H1 Receptor In Com 1e-19
4eiy_A447 Crystal Structure Of The Chimeric Protein Of A2aar- 2e-13
4eiy_A447 Crystal Structure Of The Chimeric Protein Of A2aar- 2e-09
3vg9_A326 Crystal Structure Of Human Adenosine A2a Receptor W 6e-13
3vg9_A326 Crystal Structure Of Human Adenosine A2a Receptor W 4e-09
3eml_A488 The 2.6 A Crystal Structure Of A Human A2a Adenosin 7e-13
3eml_A488 The 2.6 A Crystal Structure Of A Human A2a Adenosin 2e-08
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 1e-12
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 4e-09
3pwh_A329 Thermostabilised Adenosine A2a Receptor Length = 32 2e-12
3pwh_A329 Thermostabilised Adenosine A2a Receptor Length = 32 2e-08
4dkl_A464 Crystal Structure Of The Mu-Opioid Receptor Bound T 3e-11
4djh_A480 Structure Of The Human Kappa Opioid Receptor In Com 1e-09
2ziy_A372 Crystal Structure Of Squid Rhodopsin Length = 372 2e-09
2z73_A448 Crystal Structure Of Squid Rhodopsin Length = 448 2e-09
4ej4_A461 Structure Of The Delta Opioid Receptor Bound To Nal 4e-09
4ea3_B434 Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI 9e-09
4ea3_B434 Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI 4e-04
2ks9_A364 Solution Conformation Of Substance P In Water Compl 1e-08
3oax_A349 Crystal Structure Of Bovine Rhodopsin With Beta-Ion 4e-07
1jfp_A348 Structure Of Bovine Rhodopsin (Dark Adapted) Length 4e-07
2x72_A349 Crystal Structure Of The Constitutively Active E113 4e-07
2j4y_A349 Crystal Structure Of A Rhodopsin Stabilizing Mutant 5e-07
3c9m_A348 Structure Of A Mutant Bovine Rhodopsin In Hexagonal 5e-07
4a4m_A349 Crystal Structure Of The Light-Activated Constituti 6e-07
3v2w_A520 Crystal Structure Of A Lipid G Protein-Coupled Rece 1e-06
3vw7_A484 Crystal Structure Of Human Protease-Activated Recep 2e-05
2lnl_A296 Structure Of Human Cxcr1 In Phospholipid Bilayers L 1e-04
1hll_A32 Nmr Structure Of T3-I2, A 32 Residue Peptide From T 6e-04
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure

Iteration: 1

Score = 125 bits (315), Expect = 4e-29, Method: Compositional matrix adjust. Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 6/206 (2%) Query: 39 YSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIF 98 Y+ E + I +S +++ + GN++V+ ++ ++ L+ V N+FI SLA ADL + + Sbjct: 175 YAADEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLA 234 Query: 99 VLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQR 158 V+P + L+ W FG C+ W + DVLC TASI LC IA+DRY+AIT P Y Sbjct: 235 VVPFGAAHILTKTWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLL 294 Query: 159 TIKRVMMMIMYVWXXXXXXXXX-XXXGW-----NDWPEVFEADTPCQLTQQRGYVVYSSL 212 T + ++I+ VW W + + +T C + Y + SS+ Sbjct: 295 TKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSI 354 Query: 213 GSFFIPLAIMTLVYVEIFLATKKRLR 238 SF++PL IM VY +F K++L+ Sbjct: 355 VSFYVPLVIMVFVYSRVFQEAKRQLQ 380
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 Back     alignment and structure
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 Back     alignment and structure
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 Back     alignment and structure
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 Back     alignment and structure
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 Back     alignment and structure
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 Back     alignment and structure
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 Back     alignment and structure
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 Back     alignment and structure
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 Back     alignment and structure
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 Back     alignment and structure
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 Back     alignment and structure
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 Back     alignment and structure
>pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|2ZIY|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 372 Back     alignment and structure
>pdb|2Z73|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 448 Back     alignment and structure
>pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 Back     alignment and structure
>pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 Back     alignment and structure
>pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 Back     alignment and structure
>pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 Back     alignment and structure
>pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 Back     alignment and structure
>pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 Back     alignment and structure
>pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 Back     alignment and structure
>pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 Back     alignment and structure
>pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 Back     alignment and structure
>pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 Back     alignment and structure
>pdb|3V2W|A Chain A, Crystal Structure Of A Lipid G Protein-Coupled Receptor At 3.35a Length = 520 Back     alignment and structure
>pdb|3VW7|A Chain A, Crystal Structure Of Human Protease-Activated Receptor 1 (Par1) Bound With Antagonist Vorapaxar At 2.2 Angstrom Length = 484 Back     alignment and structure
>pdb|2LNL|A Chain A, Structure Of Human Cxcr1 In Phospholipid Bilayers Length = 296 Back     alignment and structure
>pdb|1HLL|A Chain A, Nmr Structure Of T3-I2, A 32 Residue Peptide From The Alpha- 2a Adrenergic Receptor Length = 32 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query507
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 1e-135
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 1e-132
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 1e-132
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 1e-132
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 1e-128
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 6e-99
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 7e-88
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 5e-29
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 3e-85
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 1e-27
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 1e-81
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 3e-27
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 3e-59
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 1e-46
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 3e-11
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 2e-46
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 8e-09
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 4e-43
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 4e-13
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 1e-36
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 3e-18
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 2e-31
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 2e-09
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 1e-13
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 6e-04
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
 Score =  399 bits (1027), Expect = e-135
 Identities = 109/465 (23%), Positives = 190/465 (40%), Gaps = 35/465 (7%)

Query: 42  PEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLP 101
             +E +  ++   +L + TIIGNI+V++S+   + L+ V N+F+ SLA ADL + +F + 
Sbjct: 19  KTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMN 78

Query: 102 LSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIK 161
           L  +Y + G W  G ++C +WL  D +   AS++NL  I+ DRY+ +T PL Y  +RT K
Sbjct: 79  LYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTK 138

Query: 162 RVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTP---CQLTQQRGYVVYSSLGSFFIP 218
              MMI   W+LS ++ +P ++ W     V   +      Q          +++ +F++P
Sbjct: 139 MAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLP 198

Query: 219 LAIMTLVYVEIFLATKKRLRDRA-----KASKLNIVKQTTLHNVQKEVQSPLEPESISSE 273
           + IMT++Y  I  A+K R+         +  +L I K T  +          +  S+++ 
Sbjct: 199 VIIMTVLYWHISRASKSRINIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAA 258

Query: 274 NDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSMTDIQDLSSSSNKIAARN 333
                            K   +K  N + ++ +R +L N         L +         
Sbjct: 259 KSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINM 318

Query: 334 DNMGEFVHINNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVK 393
                   +     +            A   +  +  N      K  +            
Sbjct: 319 VFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTW---- 374

Query: 394 SEVSIVVIQAPSTQVVKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLP 453
                                       S+E++  RT+  I+  F+  W P+ +M +   
Sbjct: 375 ----------------------DAYPPPSREKKVTRTILAILLAFIITWAPYNVMVLINT 412

Query: 454 FCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLL 498
           FC   C+ + +     WL YINS INP  Y + N  F+K+FK LL
Sbjct: 413 FCA-PCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLL 456


>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Length = 32 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query507
4grv_A510 Neurotensin receptor type 1, lysozyme chimera; G-p 100.0
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 100.0
3vw7_A484 Proteinase-activated receptor 1, lysozyme; high re 100.0
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 100.0
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 100.0
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 100.0
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 100.0
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 100.0
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 100.0
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 100.0
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 100.0
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 100.0
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 100.0
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 100.0
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 100.0
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 100.0
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 100.0
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 100.0
2koe_A40 Human cannabinoid receptor 1 - helix 7/8 peptide; 98.64
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 98.48
2ki9_A33 Cannabinoid receptor 2; GPCR, G-protein coupled re 97.95
2lot_A64 Apelin receptor; membrane protein; NMR {Homo sapie 95.9
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 91.0
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 84.04
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 81.37
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
Probab=100.00  E-value=7.8e-52  Score=425.73  Aligned_cols=203  Identities=19%  Similarity=0.331  Sum_probs=168.9

Q ss_pred             CcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc---chhHHHHHHHHHHHHHHHHHHHHHHHHHHhh--Ccccc
Q psy461           40 SVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLR---IVQNFFIVSLAVADLTVAIFVLPLSLIYYLS--GRWIF  114 (507)
Q Consensus        40 ~~~~~~~~~~~~~~~ii~~~gi~gN~lvi~~i~~~~~lr---~~~~~ll~~LaisDll~~~~~~p~~i~~~~~--~~~~~  114 (507)
                      +...+..++..++|++++++|++||+++++++.+.+++|   +++|+|++|||++|++++++.+|+.+...+.  +.|.+
T Consensus        26 ~~~~~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~~~w~~  105 (510)
T 4grv_A           26 NTDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVHHPWAF  105 (510)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCSSCSS
T ss_pred             ChhHHHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCEEh
Confidence            345567888899999999999999999999999876554   7889999999999999999999999887654  56999


Q ss_pred             cchhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHhhcccccccccccchhhhhHHHHHHHHHHHHhhccccccCCCcc---
Q psy461          115 GIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEV---  191 (507)
Q Consensus       115 ~~~~C~~~~~~~~~~~~~S~~~l~~IaidRy~aI~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~---  191 (507)
                      |+.+|++..++..++..+|++++++||+|||+||++|++|+..+|++++..+++++|++++++++|++++++.....   
T Consensus       106 g~~~C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~  185 (510)
T 4grv_A          106 GDAGCRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADG  185 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSS
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999998877643222   


Q ss_pred             -ccCCCccccCC----cchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q psy461          192 -FEADTPCQLTQ----QRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAK  242 (507)
Q Consensus       192 -~~~~~~c~~~~----~~~~~~~~~~~~~~ip~~vi~~~y~~I~~~l~~~~~~~~~  242 (507)
                       ......|....    ...|..+..++.|++|+++|+++|++|++.++++.+....
T Consensus       186 ~~~~~~~c~~~~~~~~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~~~~~~~~  241 (510)
T 4grv_A          186 THPGGLVCTPIVDTATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEM  241 (510)
T ss_dssp             CCGGGEEEEECSCHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHTSCTHHHH
T ss_pred             CCCCccccccccccchhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence             11222354433    2335566667788999999999999999999987655443



>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} Back     alignment and structure
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 507
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 4e-19
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 4e-15
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
 Score = 86.6 bits (213), Expect = 4e-19
 Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 8/208 (3%)

Query: 30  PSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLA 89
            S F     Y    W+  +    +  LI+     N + +     +K LR   N+ +++LA
Sbjct: 21  RSPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLA 80

Query: 90  VADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAIT 149
           VADL +       +L   L G ++FG   C +      L    ++ +L  +A++RY  + 
Sbjct: 81  VADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVC 140

Query: 150 DPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGW-------NDWPEVFEADTPCQLTQ 202
            P+    +      +M + + W+++   ++PPL+GW              +  TP + T 
Sbjct: 141 KPMSN-FRFGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETN 199

Query: 203 QRGYVVYSSLGSFFIPLAIMTLVYVEIF 230
              +V+Y  +  F IPL ++   Y ++ 
Sbjct: 200 NESFVIYMFVVHFIIPLIVIFFCYGQLV 227


>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query507
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 100.0
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 85.45
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00  E-value=4.3e-40  Score=319.74  Aligned_cols=299  Identities=20%  Similarity=0.386  Sum_probs=241.8

Q ss_pred             CCcccccccCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCcchhHHHHHHHHHHHHHHHHHHHHHHHHHHhhC
Q psy461           31 SAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSG  110 (507)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~~~~~~ii~~~gi~gN~lvi~~i~~~~~lr~~~~~ll~~LaisDll~~~~~~p~~i~~~~~~  110 (507)
                      ..|.....+-.++|...+..+++.+++++|++||+++++++.++|++|++.|+++++||++|++.++...|..+.....+
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~~~~~~~  101 (348)
T d1u19a_          22 SPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHG  101 (348)
T ss_dssp             CTTTSCCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHT
T ss_pred             CCCCCCccccccHHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence            34444566677788888999999999999999999999999999999999999999999999999999999999888888


Q ss_pred             cccccchhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHhhcccccccccccchhhhhHHHHHHHHHHHHhhccccccCCCc
Q psy461          111 RWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPE  190 (507)
Q Consensus       111 ~~~~~~~~C~~~~~~~~~~~~~S~~~l~~IaidRy~aI~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~  190 (507)
                      .|..+...|++..++..++..++++++++|++|||++|++|++|... ++++....++.+|.+++++.+++.++......
T Consensus       102 ~~~~~~~~c~~~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (348)
T d1u19a_         102 YFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRF-GENHAIMGVAFTWVMALACAAPPLVGWSRYIP  180 (348)
T ss_dssp             SCTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCCC-CHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEE
T ss_pred             ccccCchhhhhhhhccccceeeecchhhhhhcccceeeecccccccc-ccccccccceeeehhhhheecccccccceecc
Confidence            89999999999999999999999999999999999999999998654 66777888888999999999998877665432


Q ss_pred             cccCCCccccC--------CcchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhcchhccccccccccccc
Q psy461          191 VFEADTPCQLT--------QQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQKEVQ  262 (507)
Q Consensus       191 ~~~~~~~c~~~--------~~~~~~~~~~~~~~~ip~~vi~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (507)
                      . .....|...        ....+..+...+.+++|+++++++|.++.++++++.++.                      
T Consensus       181 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~y~~i~~~~~~~~~~~----------------------  237 (348)
T d1u19a_         181 E-GMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQ----------------------  237 (348)
T ss_dssp             E-TTTTEEECCCSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHHHTTTTTSSCSCCCSS----------------------
T ss_pred             C-CcccccccccccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhhccccccc----------------------
Confidence            2 222222211        122244555566678999999999999876544321000                      


Q ss_pred             CCCCCCCccccCCCCCCccccccccccchhhcccCCCCCCCccccccccccCCccccccccccchhccccCCCCccceee
Q psy461          263 SPLEPESISSENDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSMTDIQDLSSSSNKIAARNDNMGEFVHI  342 (507)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (507)
                                                                                                      
T Consensus       238 --------------------------------------------------------------------------------  237 (348)
T d1u19a_         238 --------------------------------------------------------------------------------  237 (348)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             cCCCccccccccccccccccccCCCCCCCCCCCCcCCCCCCCCCccccccccccchhhccCCChhhHHHHHHHHHhhhhH
Q psy461          343 NNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKISLS  422 (507)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (507)
                                                                                              +......+
T Consensus       238 ------------------------------------------------------------------------~~~~~~~~  245 (348)
T d1u19a_         238 ------------------------------------------------------------------------QESATTQK  245 (348)
T ss_dssp             ------------------------------------------------------------------------CSSSHHHH
T ss_pred             ------------------------------------------------------------------------chhhhhHH
Confidence                                                                                    00011235


Q ss_pred             HHHHHHHHHHHHHHHHHhhchhHHHHHhhccccCCccCchhHHHHHHHHHhhhcchhhHHHHhhcHHHHHHHHHHHHhhh
Q psy461          423 KERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVS  502 (507)
Q Consensus       423 ~~~r~~k~l~~i~~~f~i~w~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~NPiIY~~~n~~fR~~~~~l~~~~~  502 (507)
                      +++|++|++++++++|++||+|+.++.++....+.......+..+..+++++|+++||+||+++|++||++++++++|.+
T Consensus       246 ~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~~~~~l~c~~  325 (348)
T d1u19a_         246 AEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGK  325 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTSCCCHHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHHHHHHHTSSC
T ss_pred             HHhhHhheEEEeehHHHHHhhHHHhhhheeeccCCccccHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHhCCCC
Confidence            67899999999999999999999998887776666666677778888999999999999999999999999999998666


Q ss_pred             hcc
Q psy461          503 LSR  505 (507)
Q Consensus       503 ~~~  505 (507)
                      ++.
T Consensus       326 ~~~  328 (348)
T d1u19a_         326 NPL  328 (348)
T ss_dssp             CCT
T ss_pred             CCC
Confidence            543



>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure